Allogene Therapeutics, Inc. (Nasdaq: ALLO), today announced that David Chang, M.D., Ph.D., President, Chief Executive Officer and Co-Founder, will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 12:45 p.m. Pacific Time/3:45 p.m. Eastern Time.
January 4, 2022
· 2 min read